Cellular vacuolization caused by overexpression of the PIKfyve-binding deficient Vac14L156R is rescued by starvation and inhibition of vacuolar-ATPase

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1864, Issue 5, 2017, Pages 749-759

  Schulze, Ulf ^a   Vollenbröker, Beate ^a   Kühnl, Alexander ^b   Granado, Daniel ^a   Bayraktar, Samet ^a   Rescher, Ursula ^b   Pavenstädt, Hermann ^a   Weide, Thomas ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; ADENOSINE TRIPHOSPHATASE; PHOSPHATIDYLINOSITIDE; BAFILOMYCIN A; ENZYME INHIBITOR; MACROLIDE; MEMBRANE PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SERUM-FREE MEDIUM; VAC14 PROTEIN, HUMAN;

ARTICLE; CELL VACUOLE; CONTROLLED STUDY; ENDOSOME; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYSOSOME; PH MEASUREMENT; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; AMINO ACID SUBSTITUTION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; FOOD; GENETICS; HEK293 CELL LINE; METABOLISM; PHARMACOLOGY; SERUM-FREE MEDIUM; ULTRASTRUCTURE; UPREGULATION;

AMINO ACID SUBSTITUTION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; ENZYME INHIBITORS; FOOD; HEK293 CELLS; HUMANS; MACROLIDES; MEMBRANE PROTEINS; PODOCYTES; UP-REGULATION; VACUOLAR PROTON-TRANSLOCATING ATPASES; VACUOLES;

EID: 85014243992     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2017.02.012     Document Type: Article

References (42)

1. [1] Mccartney, A.J., Zhang, Y., Weisman, L.S., Phosphatidylinositol 3,5-bisphosphate: low abundance, high significance. BioEssays 36 (2014), 52–64, 10.1002/bies.201300012.
2. [2] Zolov, S.N., Bridges, D., Zhang, Y., Lee, W.-W., Riehle, E., Verma, R., Lenk, G.M., Converso-Baran, K., Weide, T., Albin, R.L., Saltiel, A.R., Meisler, M.H., Russell, M.W., Weisman, L.S., In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 17472–17477, 10.1073/pnas.1203106109.
3. [3] Ikonomov, O.C., Sbrissa, D., Fenner, H., Shisheva, A., PIKfyve-ArPIKfyve-Sac3 core complex: contact sites and their consequence for Sac3 phosphatase activity and endocytic membrane homeostasis. J. Biol. Chem. 284 (2009), 35794–35806, 10.1074/jbc.M109.037515.
4. [4] Alghamdi, T.A., Ho, C.Y., Mrakovic, A., Taylor, D., Mao, D., Botelho, R.J., Vac14 protein multimerization is a prerequisite step for Fab1 protein complex assembly and function. J. Biol. Chem. 288 (2013), 9363–9372, 10.1074/jbc.M113.453712.
5. [5] Jin, N., Chow, C.Y., Liu, L., Zolov, S.N., Bronson, R., Davisson, M., Petersen, J.L., Zhang, Y., Park, S., Duex, J.E., Goldowitz, D., Meisler, M.H., Weisman, L.S., VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P(2) in yeast and mouse. EMBO J. 27 (2008), 3221–3234, 10.1038/emboj.2008.248.
6. [6] Chow, C.Y., Zhang, Y., Dowling, J.J., Jin, N., Adamska, M., Shiga, K., Szigeti, K., Shy, M.E., Li, J., Zhang, X., Lupski, J.R., Weisman, L.S., Meisler, M.H., Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 448 (2007), 68–72, 10.1038/nature05876.
7. [7] Zhang, Y., Zolov, S.N., Chow, C.Y., Slutsky, S.G., Richardson, S.C., Piper, R.C., Yang, B., Nau, J.J., Westrick, R.J., Morrison, S.J., Meisler, M.H., Weisman, L.S., Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 17518–17523, 10.1073/pnas.0702275104.
8. [8] Jefferies, H.B.J., Cooke, F.T., Jat, P., Boucheron, C., Koizumi, T., Hayakawa, M., Kaizawa, H., Ohishi, T., Workman, P., Waterfield, M.D., Parker, P.J., A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep. 9 (2008), 164–170, 10.1038/sj.embor.7401155.
9. [9] Schulze, U., Vollenbroeker, B., Braun, D.A., Van Le, T., Granado, D., Kremerskothen, J., Fraenzel, B., Klosowski, R., Barth, J., Fufezan, C., Wolters, D.A., Pavenstadt, H., Weide, T., The Vac14-interaction network is linked to regulators of the endolysosomal and autophagic pathway. Mol. Cell. Proteomics, 2014, 1–41, 10.1074/mcp.M113.034108.
10. [10] Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S.J., Lindenmeyer, M.T., Cohen, C.D., Pavenstädt, H., Kerjaschki, D., Mizushima, N., Shaw, A.S., Walz, G., Huber, T.B., Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J. Clin. Invest. 120 (2010), 1084–1096, 10.1172/JCI39492.
11. [11] Weide, T., Huber, T.B., Implications of autophagy for glomerular aging and disease. Cell Tissue Res. 343 (2011), 467–473, 10.1007/s00441-010-1115-0.
12. [12] Riediger, F., Quack, I., Qadri, F., Hartleben, B., Park, J.-K., Potthoff, S.A., Sohn, D., Sihn, G., Rousselle, A., Fokuhl, V., Maschke, U., Purfürst, B., Schneider, W., Rump, L.C., Luft, F.C., Dechend, R., Bader, M., Huber, T.B., Nguyen, G., Muller, D.N., Prorenin receptor is essential for podocyte autophagy and survival. J. Am. Soc. Nephrol. 22 (2011), 2193–2202, 10.1681/ASN.2011020200.
13. [13] Oshima, Y., Kinouchi, K., Ichihara, A., Sakoda, M., Kurauchi-Mito, A., Bokuda, K., Narita, T., Kurosawa, H., Sun-Wada, G.-H., Wada, Y., Yamada, T., Takemoto, M., Saleem, M.A., Quaggin, S.E., Itoh, H., Prorenin receptor is essential for normal podocyte structure and function. J. Am. Soc. Nephrol. 22 (2011), 2203–2212, 10.1681/ASN.2011020202.
14. [14] Chen, J.-K.J., Chen, M.X., Fogo, A.B., Harris, R.C., Chen, J.-K.J., mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking. J. Am. Soc. Nephrol. 24 (2013), 198–207, 10.1681/ASN.2012010101.
15. [15] Bechtel, W., Helmstädter, M., Balica, J., Hartleben, B., Kiefer, B., Hrnjic, F., Schell, C., Kretz, O., Liu, S., Geist, F., Kerjaschki, D., Walz, G., Huber, T.B., Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis. J. Am. Soc. Nephrol. 24 (2013), 727–743, 10.1681/ASN.2012070700.
16. [16] Cinà, D.P., Onay, T., Paltoo, A., Li, C., Maezawa, Y., De Arteaga, J., Jurisicova, A., Quaggin, S.E., Inhibition of MTOR disrupts autophagic flux in podocytes. J. Am. Soc. Nephrol. 23 (2012), 412–420, 10.1681/ASN.2011070690.
17. [17] Settembre, C., Fraldi, A., Medina, D.L., Ballabio, A., Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 14 (2013), 283–296, 10.1038/nrm3565.
18. [18] Sarbassov, D.D., Ali, S.M., Kim, D.-H., Guertin, D.A., Latek, R.R., Erdjument-Bromage, H., Tempst, P., Sabatini, D.M., Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14 (2004), 1296–1302, 10.1016/j.cub.2004.06.054.
19. [19] Kim, D.-H., Sarbassov, D.D., Ali, S.M., Latek, R.R., Guntur, K.V.P., Erdjument-Bromage, H., Tempst, P., Sabatini, D.M., GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell 11 (2003), 895–904 ( http://www.ncbi.nlm.nih.gov/pubmed/12718876 (accessed April 27, 2016)).
20. [20] Wennmann, D.O., Vollenbröker, B., Eckart, A.K., Bonse, J., Erdmann, F., Wolters, D.A., Schenk, L.K., Schulze, U., Kremerskothen, J., Weide, T., Pavenstädt, H., The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes. Cell Death Dis., 5, 2014, e1519, 10.1038/cddis.2014.476.
21. [21] Djuric, I., Siebrasse, J.P., Schulze, U., Granado, D., Schlüter, M.A., Kubitscheck, U., Pavenstädt, H., Weide, T., The C-terminal domain controls the mobility of Crumbs 3 isoforms. Biochim. Biophys. Acta 1863 (2016), 1208–1217, 10.1016/j.bbamcr.2016.03.008.
22. [22] Johnson, D.E., Ostrowski, P., Jaumouillé, V., Grinstein, S., The position of lysosomes within the cell determines their luminal pH. J. Cell Biol. 212 (2016), 677–692, 10.1083/jcb.201507112.
23. [23] MANDERS, E.M.M., VERBEEK, F.J., ATEN, J.A., Measurement of co-localization of objects in dual-colour confocal images. J. Microsc. 169 (1993), 375–382, 10.1111/j.1365-2818.1993.tb03313.x.
24. [24] Lim, J.P., Gleeson, P.A., Macropinocytosis: an endocytic pathway for internalising large gulps. Immunol. Cell Biol. 89 (2011), 836–843, 10.1038/icb.2011.20.
25. [25] Barbero, P., Bittova, L., Pfeffer, S.R., Visualization of Rab9-mediated vesicle transport from endosomes to the trans-Golgi in living cells. J. Cell Biol. 156 (2002), 511–518, 10.1083/jcb.200109030.
26. [26] Wernick, N.L.B., Chinnapen, D.J.-F., Cho, J.A., Lencer, W.I., Cholera toxin: an intracellular journey into the cytosol by way of the endoplasmic reticulum. Toxins (Basel) 2 (2010), 310–325, 10.3390/toxins2030310.
27. [27] Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A.L., Nada, S., Sabatini, D.M., Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141 (2010), 290–303, 10.1016/j.cell.2010.02.024.
28. [28] Avruch, J., Hara, K., Lin, Y., Liu, M., Long, X., Ortiz-Vega, S., Yonezawa, K., Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 25 (2006), 6361–6372, 10.1038/sj.onc.1209882.
29. [29] Mundy, D.I., Li, W.P., Luby-Phelps, K., Anderson, R.G.W., Caveolin targeting to late endosome/lysosomal membranes is induced by perturbations of lysosomal pH and cholesterol content. Mol. Biol. Cell 23 (2012), 864–880, 10.1091/mbc.E11-07-0598.
30. [30] Cuervo, A.M., Wong, E., Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 24 (2014), 92–104, 10.1038/cr.2013.153.
31. [31] Lafourcade, C., Sobo, K., Kieffer-Jaquinod, S., Garin, J., van der Goot, F.G., Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization. PLoS One, 3, 2008, e2758, 10.1371/journal.pone.0002758.
32. [32] Lu, F., Liang, Q., Abi-Mosleh, L., Das, A., De Brabander, J.K., Goldstein, J.L., Brown, M.S., Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. elife, 4, 2015, e12177, 10.7554/eLife.12177.
33. [33] Ferguson, C.J., Lenk, G.M., Meisler, M.H., Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2. Hum. Mol. Genet. 18 (2009), 4868–4878, 10.1093/hmg/ddp460.
34. [34] Wiggins, R.-C., The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 71 (2007), 1205–1214, 10.1038/sj.ki.5002222.
35. [35] Scott, R.P., Quaggin, S.E., The cell biology of renal filtration. J. Cell Biol. 209 (2015), 199–210, 10.1083/jcb.201410017.
36. [36] Zoncu, R., Bar-Peled, L., Efeyan, A., Wang, S., Sancak, Y., Sabatini, D.M., mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 334 (2011), 678–683, 10.1126/science.1207056.
37. [37] Bar-Peled, L., Schweitzer, L.D., Zoncu, R., Sabatini, D.M., Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 150 (2012), 1196–1208, 10.1016/j.cell.2012.07.032.
38. [38] Ludwig, J., Kerscher, S., Brandt, U., Pfeiffer, K., Getlawi, F., Apps, D.K., Schagger, H., Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J. Biol. Chem. 273 (1998), 10939–10947, 10.1074/jbc.273.18.10939.
39. 2 loss under PIKfyve or Vps34 deficiency. Am. J. Physiol. Cell Physiol. 311 (2016), C366–C377, 10.1152/ajpcell.00104.2016.
40. [40] Aki, T., Nara, A., Uemura, K., Cytoplasmic vacuolization during exposure to drugs and other substances. Cell Biol. Toxicol. 28 (2012), 125–131, 10.1007/s10565-012-9212-3.
41. [41] Boquet, P., Ricci, V., Intoxication strategy of Helicobacter pylori VacA toxin. Trends Microbiol. 20 (2012), 165–174, 10.1016/j.tim.2012.01.008.
42. [42] Marceau, F., Bawolak, M.-T., Lodge, R., Bouthillier, J., Gagné-Henley, A., Gaudreault, R.C., Morissette, G., Cation trapping by cellular acidic compartments: beyond the concept of lysosomotropic drugs. Toxicol. Appl. Pharmacol. 259 (2012), 1–12, 10.1016/j.taap.2011.12.004.